Erwin G. Van Meir

Erwin G. Van Meir's AcademicInfluence.com Rankings

Erwin G. Van Meir

Philosophy

#8170

World Rank

#11498

Historical Rank

Logic

#5200

World Rank

#6579

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Erwin G. Van Meir's Degrees

PhD Biomedical Sciences University of Antwerp
Masters Biomedical Sciences University of Antwerp

Why Is Erwin G. Van Meir Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Erwin G. Van Meir's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) (5775)
The Somatic Genomic Landscape of Glioblastoma (2013) (3693)
The Immune Landscape of Cancer (2018) (2766)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (2015) (2211)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma (2010) (1301)
Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. (2001) (814)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes (2012) (760)
Intertumoral Heterogeneity within Medulloblastoma Subgroups. (2017) (703)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. (2005) (682)
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. (2005) (593)
Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons (2010) (544)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
'Pseudopalisading' Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis (2006) (496)
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. (2004) (495)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? (1997) (436)
Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population (2004) (408)
Patterns of somatic structural variation in human cancer genomes (2020) (377)
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. (2013) (362)
Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells (1994) (346)
Analysis of the p53 gene and its expression in human glioblastoma cells. (1994) (340)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. (2008) (313)
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. (2002) (311)
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution (2015) (307)
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma (2004) (293)
Overcoming therapeutic resistance in glioblastoma: the way forward. (2017) (292)
Divergent clonal selection dominates medulloblastoma at recurrence (2016) (266)
Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. (2001) (258)
Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis (1997) (253)
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development (2013) (249)
Cytogenetic prognostication within medulloblastoma subgroups. (2014) (242)
Human glioblastoma cells release interleukin 6 in vivo and in vitro. (1990) (241)
PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. (2005) (226)
LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS (2019) (223)
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. (2014) (220)
Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
Brain tumor-polyposis syndrome: two genetic diseases? (1997) (195)
The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. (2012) (194)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses (1998) (177)
Thrombospondins and tumor angiogenesis. (2001) (174)
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor (2005) (170)
Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 (2002) (166)
Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer (2004) (161)
Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro (1994) (161)
Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. (2005) (157)
Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis (2016) (156)
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. (1992) (155)
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma (2000) (155)
Fas Ligand Expression in Glioblastoma Cell Lines and Primary Astrocytic Brain Tumors (1997) (149)
Genetic and hypoxic regulation of angiogenesis in gliomas (2004) (149)
Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. (2003) (146)
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma (2013) (146)
Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. (2001) (144)
The Somatic Genomic Landscape of Glioblastoma (2014) (135)
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy (2003) (134)
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. (2002) (133)
Brain cancer propagating cells: biology, genetics and targeted therapies. (2009) (128)
The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. (1999) (127)
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. (2016) (127)
Differential expression of the CD44 molecule in human brain tumours (1992) (122)
Hypoxia inducible factor-1: a novel target for cancer therapy (2005) (122)
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. (1999) (122)
Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. (2009) (120)
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma (1999) (120)
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. (2013) (117)
Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth (2004) (114)
Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. (2009) (114)
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells (2001) (113)
Vaccinia virus produces late mRNAs by discontinuous synthesis (1987) (110)
Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells (2000) (110)
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. (2004) (109)
Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4. (2007) (104)
Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. (2003) (104)
Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation (2002) (102)
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium (2018) (102)
Functional evolution of ADAMTS genes: Evidence from analyses of phylogeny and gene organization (2005) (100)
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia (2004) (98)
Tumor initiating cells in malignant gliomas: biology and implications for therapy (2009) (97)
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. (2006) (94)
Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas (1998) (92)
Identification of a Novel Small Molecule HIF-1α Translation Inhibitor (2009) (91)
Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma (2012) (90)
Brain-specific Angiogenesis Inhibitor-1 Signaling, Regulation, and Enrichment in the Postsynaptic Density* (2013) (89)
Replicative oncolytic adenoviruses in multimodal cancer regimens. (2003) (89)
Proteomics of gliomas: initial biomarker discovery and evolution of technology. (2011) (86)
PIKE (Phosphatidylinositol 3-Kinase Enhancer)-A GTPase Stimulates Akt Activity and Mediates Cellular Invasion* (2004) (86)
Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. (1993) (82)
Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. (2014) (82)
Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor (1999) (82)
Necrogenesis and Fas/APO-1 (CD95) Expression in Primary (de novo) and Secondary Glioblastomas (1998) (81)
Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. (2006) (79)
Biology of advanced uveal melanoma and next steps for clinical therapeutics (2014) (79)
Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. (2003) (73)
A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1 (2012) (71)
Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas (2001) (71)
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma (2019) (71)
Cytokine regulation of intercellular adhesion molecule‐1 (ICAM‐1) expression on human glioblastoma cells (1990) (70)
Proteomic identification of the wt-p53-regulated tumor cell secretome (2006) (68)
Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors (2007) (68)
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. (2007) (67)
Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors (2004) (67)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. (1992) (66)
An Integrative Approach for In Silico Glioma Research (2010) (65)
Functional analysis of the 5′ flanking sequence of a vaccinia virus late gene. (1986) (64)
Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development (2011) (63)
Cytokines and tumors of the central nervous system (1995) (62)
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP (2012) (61)
New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26 (1997) (61)
Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. (1995) (60)
BAI1 regulates spatial learning and synaptic plasticity in the hippocampus. (2015) (59)
Glioblastoma Cancer Stem-Like Cells: Implications for Pathogenesis and Treatment (2012) (59)
Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. (2011) (59)
A novel cyclic analog of neuropeptide Y specific for the Y2 receptor. (1992) (58)
Integrative, Multimodal Analysis of Glioblastoma Using TCGA Molecular Data, Pathology Images, and Clinical Outcomes (2011) (58)
Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin. (2010) (57)
Glioma progression is shaped by genetic evolution and microenvironment interactions (2022) (56)
Replicative oncolytic herpes simplex viruses in combination cancer therapies. (2004) (56)
Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay (1998) (55)
Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers (2006) (55)
Cytokines and tumors of the central nervous system. (1995) (54)
Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment. (2008) (51)
Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1 (2003) (50)
Response of bovine endothelial cells to FGF‐2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis (2001) (50)
Erratum: The somatic genomic landscape of glioblastoma (Cell (2013) 155 (462-477)) (2014) (49)
Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma (2019) (49)
Stat3 activation is required for the growth of U87 cell-derived tumours in mice. (2009) (45)
Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway. (2011) (45)
Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration (2006) (44)
Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma (2018) (42)
Genetic instability leads to loss of both p53 alleles in a human glioblastoma (1998) (42)
P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. (2012) (42)
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma (2014) (42)
Adhesion GPCRs in Tumorigenesis. (2016) (42)
Sex differences in oncogenic mutational processes (2019) (41)
Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents. (2012) (40)
BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. (2018) (38)
Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors. (2011) (37)
Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma (2018) (37)
Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase (2016) (36)
Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). (2003) (33)
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. (2002) (33)
A role for activated Cdc42 in glioblastoma multiforme invasion (2016) (32)
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology (2012) (32)
Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent. (2012) (31)
Genomic Alterations in Human Malignant Glioma Cells Associate with the Cell Resistance to the Combination Treatment with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy (2006) (30)
Absence of KLF6 gene mutations in human astrocytic tumors and cell lines (2004) (29)
Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene. (1993) (28)
Erratum: Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4 (Cancer Research (2007) 67, (6872-6881)) (2007) (27)
Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-877) (1993) (27)
Inhibitors of hypoxia-inducible factor-1 signaling. (2006) (26)
A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis (2019) (26)
The transcriptional landscape of Shh medulloblastoma (2021) (26)
Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma. (2002) (25)
Turcot's syndrome: Phenotype of brain tumors, survival and mode of inheritance (1998) (25)
Cytosolic pH sensitivity of an expressed human NHE-1 Na(+)-H+ exchanger. (1993) (25)
N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. (2021) (25)
BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy (2016) (24)
IL-6 stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. (1994) (23)
SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma (2014) (22)
A simple p 53 functional assay for screening cell lines , blood , and tumors ( tumor-suppressor gene / Li-Fraumeni syndrome / transcription factor / mutation detection / ADE 2 gene ) (22)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
EZH2 targeting in medulloblastoma reduces tumor growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway (2019) (21)
Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. (1996) (21)
Exciting New Advances in Neuro-Oncology (20)
CD44 expression and growth factors. (1998) (20)
Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor. (2012) (19)
Turcot's syndrome: Phenotype of brain tumors, survival and mode of inheritance (1998) (19)
Intervening sequences in the ribosomal RNA genes of Ascaris lumbricoides: DNA sequences at junctions and genomic organization. (1984) (16)
Cancer scene investigation: how a cold virus became a tumor killer. (2005) (16)
Failure of human rhombic lip differentiation underlies medulloblastoma formation (2022) (16)
Cancer therapy: Neutrophils traffic in cancer nanodrugs. (2017) (16)
Pineoblastoma presenting in familial adenomatous polyposis (FAP): random association, FAP variant or Turcot syndrome? (1998) (16)
At the crossroads of cancer and inflammation: Ras rewires an HIF-driven IL-1 autocrine loop (2011) (16)
Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system (1995) (15)
Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. (2000) (15)
Subgroup and subtype-specific outcomes in adult medulloblastoma (2021) (15)
Emerging molecular therapies for brain tumors. (2004) (15)
Use of the DSM in marriage and family therapy programs: current practices and attitudes. (1997) (14)
Restoration of endogenous wild‐type p53 activity in a glioblastoma cell line with intrinsic temperature‐sensitive p53 induces growth arrest but not apoptosis (2001) (14)
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma (2020) (14)
p53 Pathway Alterations in Brain Tumors (2009) (14)
Advances in Brief Geldanamycin Induces Degradation of Hypoxia-inducible Factor 1 Protein via the Proteosome Pathway in Prostate Cancer Cells 1 (2002) (13)
P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. (2014) (13)
Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain (2017) (13)
p53 and the CNS: tumors and developmental abnormalities. (1999) (12)
The expanding functional roles and signaling mechanisms of adhesion G protein–coupled receptors (2019) (11)
Identification of nude mice in tumorigenicity assays. (1997) (10)
Identification of nude mice in tumorigenicity assays (1997) (10)
OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2021) (10)
Opening the chamber of peer-review secrets (2004) (10)
Overexpression of MBD 2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Anti-Angiogenic Function of the Tumor Suppressor Gene BAI 1 (2011) (10)
BAP1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization (9)
A conspiracy of glioma and endothelial cells to invade the normal brain (2011) (9)
p53 and the CNS (1999) (8)
Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway. (2017) (8)
Stereologic evaluation of the pig gastric wall and of somatostatinergic and serotoninergic immunoreactive mucosal cells during perinatal development. (2001) (8)
Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway (2019) (8)
A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis (2020) (7)
Application of advances in molecular biology to the treatment of brain tumors (2000) (7)
A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis (2017) (7)
Fine structure of the vaccinia virus gene encoding the precursor of the major core protein 4 a (2005) (7)
Proteomic Discovery of Biomarkers in the Cerebrospinal Fluid of Brain Tumor Patients (2009) (6)
Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility (2017) (6)
Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth (2021) (6)
Genesis and genetics of intracranial germ cell tumors (1998) (5)
Opening the chamber of peer-review secrets (2004) (5)
Spectromicroscopy of boron for the optimization of boron neutron capture therapy (BNCT) for cancer (1998) (4)
Cytokine Expression and Signaling in Brain Tumors (2005) (4)
Taking a HIF pill for old age diseases? (2018) (4)
BAI1: from cancer to neurological disease (2016) (4)
Mice lacking full length Adgrb1 (Bai1) exhibit social deficits, increased seizure susceptibility, and altered brain development (2022) (3)
Oxygen and Nitrogen Species in Malignant Glioma Cells Inactivation of Wild-Type p 53 Protein Function by Reactive Updated (2003) (2)
Integrative, Multi-modal Analysis of Glioblastoma Using TCGA Molecular Data, Pathology Images and Clinical Outcomes (2011) (2)
A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis (2019) (2)
Suppressed Expression of T-Cell Costimulatory Molecules B7 and B70 in Human Glioblastomas In Vivo (1996) (2)
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis (2021) (2)
Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example. (2017) (2)
Microsatellite instability in human brain tumors. (1995) (2)
PIKE (PI 3-kinase-enhancer)-A GTPase stimulates Akt activity and regulates cancer cell invasion By (2004) (2)
CELL BIOLOGY AND SIGNALING (2010) (2)
Microsatellite instability in human brain tumors. (1995) (1)
Ten-eleven translocation protein 1 modulates medulloblastoma progression (2021) (1)
Intertumoral Heterogeneity within Medulloblastoma Subgroups Graphical (2017) (1)
LAB-CELL BIOLOGY AND SIGNALING (2012) (1)
A NOVEL P53 BYSTANDER EFFECT INDUCES GLIOBLASTOMA CELL DEATH THROUGH A GLYCOSYLATION-DEPENDENT MECHANISM (2014) (1)
Omics and Prognostic Markers (2010) (1)
Efficacy of A Novel Anti-tumor Agent KCN1 in the Control of Ocular Melanoma In vitro and In vivo (2013) (1)
CS-38BAI1 IS A NEW TUMOR SUPPRESSOR IN MEDULLOBLASTOMA. (2014) (1)
Design and in vitro activities of N -alkyl- N -[(8- R -2,2-dimethyl- 2H -chromen-6-yl)methyl]heteroarylsulfonamides, novel small molecule Hypoxia Inducible Factor-1 (HIF-1) pathway inhibitors and anti-cancer agents (2013) (1)
Synchrotron spectromicroscopy for microchemical analysis of boron in rat brain tumor treated with BSH (1997) (1)
Mechanisms Independent − through Hypoxia-Inducible Factor-1 Expression of Tissue Factor in Glioblastoma Multiforme Early Growth Response Gene-1 Regulates Hypoxia-Induced Updated (2006) (1)
Abstract 3078: IGF1/N-cadherin/b-catenin/Clusterin signaling axis can mediates adaptive radioresistance in glioblastoma (2021) (1)
Glioblastoma Growth Noscapine Crosses the Blood-Brain Barrier and Inhibits (2004) (1)
The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen (2021) (1)
Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker. (2019) (1)
Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p 53 alleles to glioblastoma cells ( glioma / astrocytoma / brain tumor / tumor suppressor / gene transfer ) (2005) (1)
Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY (2012) (1)
Corrigendum to “Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains” [Gene 298 (2002) 69–77] (2003) (0)
THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
Methylation of the novel apoptotic gene TMS1/ASC in human glioblastoma multiforme (2002) (0)
CSIG-25. BAI1/ADGRB1 REGULATES TGFβ1-INDUCED MESENCHYMAL SWITCH IN MEDULLOBLASTOMA (2021) (0)
Abstract 3477: ADGRB3 is epigenetically silenced in WNT-medulloblastoma and inhibits WNT signaling (2019) (0)
Abstract 1430: N-cadherin is a driver of adaptive radioresistance in malignant brain tumors (2022) (0)
A FURIN/MMP-14 PROTEOLYTIC CASCADE CLEAVES BAI1 INTO NOVEL ANGIOGENESIS INHIBITOR VASCULOSTATIN-40 (2011) (0)
Abstract LB-50: TRIM3, the human homolog of Drosophila Brat, is a tumor suppressor that regulates asymmetric cell division (ACD) in glioblastoma stem cells (2014) (0)
PDTM-12. ADGRB3 IS EPIGENETICALLY SILENCED IN WNT-MEDULLOBLASTOMA AND ITS REACTIVATION HAS THERAPEUTIC BENEFITS (2019) (0)
Glioblastoma Secrete Mcp-1, A Monocyte Chemotactic Factor (1993) (0)
Abstract 926: Experimental therapy of pancreatic cancer with KCN1, a novel anticancer agent targeting HIF-1α pathway (2012) (0)
Tumor Models (In Vivo/In Vitro) (2010) (0)
5-D confocal imaging to visualize glioblastoma spheroid invasion into the extracellular matrix (2012) (0)
STMC-17. N-CADHERIN UPREGULATION MEDIATES SLOW PROLIFERATION AND THERAPEUTIC RESISTANCE IN GLIOMA STEM CELLS (2016) (0)
Impact of p53 mutation and hypoxia on gene expression in glioblastoma (2006) (0)
Advances in Brief T \ ircot ' s Syndrome of Glioma and Polyposis Occurs in the Absence of Germ Line Mutations of Exons 5 to 9 of the p 53 Gene 1 (2006) (0)
PDTM-27. EPIGENETIC LOSS OF BAI1 EXPRESSION IN CEREBELLAR GRANULE NEURON PRECURSORS INACTIVATES THE p53 TUMOR SUPPRESSOR AND FACILITATES MEDULLOBLASTOMA FORMATION IN THE CEREBELLUM (2018) (0)
Abstract 3433: A furin/MMP-14 signaling cascade processes BAI1 into a novel secreted anti-angiogenic and anti-tumorigenic factor, Vasculostatin-40 (Vstat40) (2010) (0)
Hybrid Cellular Continuum Simulations of Heterogeneity in Tumor Growth (2010) (0)
Glioblastoma therapeutic challenge : preventing and treating tumor recurrence (2017) (0)
CSIG-35. TARGETING HYPOXIC CANCER CELLS IN MEDULLOBLASTOMA (2022) (0)
Abstract 2743: Targeting Ewing sarcoma with a new small molecule binding to the EWS-FLI1 oncoprotein. (2013) (0)
Abstract B130: The intratumoral heterogeneity of glioblastoma suggests a pivotal role for clonal evolution. (2013) (0)
Design and Synthesis of Inhibitors of the HIF-1 Pathway (2014) (0)
Small Molecule Hif Inhibitor Kcn1 Reduces Primary Ocular Melanoma and Hepatic Micrometastases in a Murine Ocular Melanoma Model (2009) (0)
The Development of Targeted Cancer Gene-Therapy Adenoviruses for High-Grade Glioma Treatment (2009) (0)
DETECTING AND QUANTIFYING 2 HG AND ALTERATIONS IN METABOLITE PROFILES IN IDH 1 / 2 MUTATION BEARING BRAIN TUMORS BY SOLID STATE HRMAS NMR (2011) (0)
the ( De ) Toxifying Enzyme Microsomal Epoxide Hydrolase Identification of the Putative Brain Tumor Antigen BF 7 / GE 2 as Updated (2000) (0)
BAI1 is a brain-specific tumor suppressor (2016) (0)
Effects of Antisense DNA Oligonucleotides of Lactate Dehydrogenase and Glucose-6-Phosphate Dehydrogenase Genes on Proliferation of Confluent Cultures of U251 Glioblastoma Cells (1991) (0)
Abstract 984: Alteration of the p53 pathway is associated with subclonal tumor progression in glioblastoma (2014) (0)
Abstract 1996: Epigenetic reactivation of BAI1/ADGRB1 suppresses tumor invasion by preventing TGFβ1-induced mesenchymal switch in glioblastoma (2019) (0)
Thérapie génique du cancer : Une explosion de nouvelles stratégies thérapeutiques (1997) (0)
Abstract B17: ADGRB3 is a novel tumor suppressor epigenetically silenced in WNT medulloblastoma (2018) (0)
Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma (2012) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
GE-17ALTERATION OF THE p53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
Proteomic analysis of factors secreted by glioblastoma that induce endothelial tissue factor (2008) (0)
Immunbiologie und Immuntherapie der Gliome (1991) (0)
Abstract 1264: Extracellular galectin-3 induces tumor-specific apoptosis through the interaction with highly glycosylated cell surface β1 integrin (2010) (0)
Design, synthesis and evaluation of the cytotoxicity of a N-mustard and paclitaxel conjugate prodrug (2013) (0)
Editors & Editorial Board (2010) (0)
Glioma Through the Looking GLASS: the Glioma Longitudinal Analysis consortium, molecular evolution of diffuse gliomas (2017) (0)
The epigenetic evolution of gliomas is determined by their 1 IDH 1 mutation status and treatment regimen 2 3 (2021) (0)
Riccardo (Rico) Wittek (1944-2008) (2009) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
Abstract 1296: Arylsulfonamide KCN1 suppresses primary and metastatic growth of uveal melanoma through anti-angiogenic and anti-invasion mechanisms (2019) (0)
The advent of precision epigenetics for medulloblastoma (2020) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
9th Adhesion GPCR Workshop Abstract Booklet (2018) (0)
STEM-16. IGF1/N-CADHERIN/b-CATENIN/CLUSTERIN SIGNALING AXIS MEDIATES ADAPTIVE RADIORESISTANCE IN GLIOBLASTOMA (2020) (0)
Inhibiteurs de hif-1 (2004) (0)
INVESTIGATION OF THE CORRELATION OF MRS MEASURABLE 2-HYDROXYGLUTARATE ( 2 HG ) CONCENTRATION AND TUMOR PROGRESSION IN BRAIN TUMORS HARBORING IDH 1 / 2 MUTATIONS (2012) (0)
Preparation of Recombinant Galectin-3 for Cancer Studies (2016) (0)
Is Fas ligand (CD95L) expression by astrocytoma cells a major mechanism of inactivation of tumour infiltrating lymphocytes (1997) (0)
ANGI-08. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION, RECURRENCE, AND SPINAL METASTASIS BY PREVENTING TGFΒ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA (2022) (0)
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma (2014) (0)
Inhibiteurs à petites molécules de hif et d'angiogenèse (2009) (0)
DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM (2018) (0)
[Overexpression of p53 protein in gliomas]. (1994) (0)
The Diaspora Haggadah - mit Umschrift versehene Pessach Hagada (1989) (0)
CSIG-30. EPIGENETIC REACTIVATION OF BAI1 BLOCKS ONCOGENIC IGF1R SIGNALLING IN MEDULLOBLASTOMA (2022) (0)
Abstract 2168: Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2022) (0)
Brain Metastases but not in Glioblastomas Variant CD 44 Adhesion Molecules Are Expressed in Human Updated (2006) (0)
CADD-26. SMALL MOLECULE EPIGENETIC TARGETING OF METHYL-CPG BINDING PROTEIN 2 (MBD2) FOR MEDULLOBLASTOMA THERAPY (2018) (0)
Abstracts (1926) (0)
Cancer Therapy : Preclinical Arylsulfonamide KCN 1 Inhibits In Vivo Glioma Growth and Interfereswith HIF Signaling byDisrupting HIF-1 a Interaction with Cofactors p 300 / CBP (2012) (0)
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation (2022) (0)
Inhibiteurs du facteur de transcription hif (2006) (0)
Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
MB-05BAI1 IS A TUMOR SUPPRESSOR IN MEDULLOBLASTOMA (2016) (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Longitudinal molecular trajectories of diffuse glioma in adults (2019) (0)
ANGI-14. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION BY PREVENTING TGFβ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA (2018) (0)
Abstract 3305: Trim3, the human homolog of Drosophila brat, regulates asymmetric division in glioblastoma stem cells (2011) (0)
Ten-eleven translocation protein 1 modulates medulloblastoma progression (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Erwin G. Van Meir?

Erwin G. Van Meir is affiliated with the following schools: